Clal Biotechnology Industries
Tel Aviv, Tel Aviv Districtcbi.co.il
Overview
Clal Biotechnology Industries (CBI) is a premier life sciences investment firm listed on the Tel Aviv Stock Exchange . CBI specializes in identifying and nurturing groundbreaking ventures that develop proprietary solutions to address unmet medical needs with substantial market potential . CBI's investments range from biotech and pharma to diagnostics and medical devices . The firm invests in companies ranging from seed to maturity, both public and private .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Classiq Technologies | May 2025 | Series C | - |
| TytoCare | Aug 2023 | VC Round | - |
| Bluewhite | Sep 2021 | Series B | - |
| Sight Diagnostics | Aug 2020 | Series D | - |
| Sight Diagnostics | Feb 2019 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
